Aidy
AboutFeaturesGalleryLearn

Partners

Patient ServicesMedical Affairs & HEORSpecialty PharmaciesGI Providers

Category

Biologics & Advanced Therapies

Modern targeted treatments for moderate-severe IBD

When a Biologic Worked and Then Stopped: A Guide to Secondary Loss of Response
Biologics & Advanced TherapiesJun 15, 2026

When a Biologic Worked and Then Stopped: A Guide to Secondary Loss of Response

Has your IBD biologic stopped working? Learn how inflammation tests, trough levels and antibody results guide dose escalation, added therapy or switching.

What to Do When an IBD Infusion or Injection Is Delayed
Biologics & Advanced TherapiesJun 24, 2026

What to Do When an IBD Infusion or Injection Is Delayed

IBD infusion or injection delayed? Learn who to call first, what to document, why a few days differ from months, and how to prevent repeat gaps.

What to Ask Before Switching to an IBD Biosimilar
Biologics & Advanced TherapiesJun 27, 2026

What to Ask Before Switching to an IBD Biosimilar

Switching to an IBD biosimilar? Use this question checklist to confirm why, dosing, monitoring, interchangeability, and your baseline with your GI.

Symptoms Return Before Your Next Biologic Dose: What to Track and Report
Biologics & Advanced TherapiesJul 17, 2026

Symptoms Return Before Your Next Biologic Dose: What to Track and Report

Biologic wearing off before your next dose? Track symptoms, dose dates and biomarkers across 3 to 4 cycles, then prepare a clear report for your GI.

Starting an IL-23 Medication for IBD: Induction, Maintenance, and Response Tracking
Biologics & Advanced TherapiesJul 21, 2026

Starting an IL-23 Medication for IBD: Induction, Maintenance, and Response Tracking

IL-23 medications for IBD follow induction at weeks 0, 4, and 8 before maintenance. Compare Skyrizi, Omvoh, and Tremfya and learn what to track.

IBD Injection-Site Reactions: What Is Common and What Deserves a Call
Biologics & Advanced TherapiesJun 24, 2026

IBD Injection-Site Reactions: What Is Common and What Deserves a Call

IBD injection-site reactions: learn which redness, swelling and pain are typical, when to call your care team or 911, and what to track after each dose.

IBD Infusion-Day Checklist: Medication, Hydration, Symptoms, and Questions
Biologics & Advanced TherapiesJun 23, 2026

IBD Infusion-Day Checklist: Medication, Hydration, Symptoms, and Questions

IBD infusion day checklist: organize hydration, medications, symptom records, reactions, lab questions, and follow-up details before your appointment.

How to Tell Whether Your Biologic Is Working: Symptoms, Calprotectin, and Scope Results
Biologics & Advanced TherapiesJun 13, 2026

How to Tell Whether Your Biologic Is Working: Symptoms, Calprotectin, and Scope Results

How to tell if your biologic is working: compare symptom trends, calprotectin and CRP, and scope results, plus when to reassess or test drug levels.

Biologic Trough Levels and Antibodies: A Patient Guide to Therapeutic Drug Monitoring
Biologics & Advanced TherapiesMay 2, 2026

Biologic Trough Levels and Antibodies: A Patient Guide to Therapeutic Drug Monitoring

Biologic trough levels and antibodies in IBD: learn when to test, what 4 result patterns mean, and how they can guide dosing or treatment changes.

Tysabri vs Tremfya for Crohn's Disease: Key Differences
Biologics & Advanced TherapiesAug 14, 2025

Tysabri vs Tremfya for Crohn's Disease: Key Differences

Tysabri vs Tremfya for Crohn's: compare efficacy, PML risk, TOUCH restrictions, and IV vs at-home dosing so you can discuss options with your GI.

Tysabri vs Stelara for Crohn's Disease: How They Compare
Biologics & Advanced TherapiesAug 13, 2025

Tysabri vs Stelara for Crohn's Disease: How They Compare

Tysabri vs Stelara for Crohn’s: compare efficacy, safety, dosing, PML risk and TOUCH restrictions, and learn why Stelara is usually tried first.

Tysabri vs Skyrizi for Crohn's Disease: Which to Choose?
Biologics & Advanced TherapiesAug 12, 2025

Tysabri vs Skyrizi for Crohn's Disease: Which to Choose?

Tysabri vs Skyrizi for Crohn's: compare efficacy, PML risk, TOUCH restrictions and dosing to prepare for a shared decision with your GI.